KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Vir Biotechnology (VIR) Revenue (2018 - 2025)

Vir Biotechnology's Revenue history spans 8 years, with the latest figure at $64.1 million for Q4 2025.

  • For Q4 2025, Revenue rose 417.78% year-over-year to $64.1 million; the TTM value through Dec 2025 reached $68.6 million, down 1.4%, while the annual FY2025 figure was $68.6 million, 7.61% down from the prior year.
  • Revenue for Q4 2025 was $64.1 million at Vir Biotechnology, up from $240000.0 in the prior quarter.
  • Across five years, Revenue topped out at $1.2 billion in Q1 2022 and bottomed at $240000.0 in Q3 2025.
  • The 5-year median for Revenue is $28.7 million (2022), against an average of $150.8 million.
  • The largest annual shift saw Revenue surged 62271.41% in 2022 before it tumbled 99.3% in 2023.
  • A 5-year view of Revenue shows it stood at $821.5 million in 2021, then tumbled by 93.99% to $49.4 million in 2022, then plummeted by 66.03% to $16.8 million in 2023, then fell by 26.29% to $12.4 million in 2024, then skyrocketed by 417.78% to $64.1 million in 2025.
  • Per Business Quant, the three most recent readings for VIR's Revenue are $64.1 million (Q4 2025), $240000.0 (Q3 2025), and $1.2 million (Q2 2025).